Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 17Hyperandrogenism 6Endometrial Neoplasms 4Breast Neoplasms 3Osteoporosis 2Endometrial Hyperplasia 2Uterine Cervical Dysplasia 1Sleep Apnea, Obstructive 1Sleep Apnea Syndromes 1Progesterone Resistance 1Obesity 1Menorrhagia 1Leiomyoma 1Infertility, Female 1Infertility 1Hot Flashes 1Gliosarcoma 1Glioblastoma 1Coronary Disease 1Cardiovascular Diseases 1Brain Neoplasms 1Anovulation 1Abortion, Spontaneous 1

Interventions

Letrozole 2Progesterone 1LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1Cyproterone acetate, ethinyl estradiol drug combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Progesterone Resistance × Progesterone × Clear all
NCT05062135 2022-01-20

Progesterone Action on Endometrium of PCOS

University of Sao Paulo General Hospital

Phase NA Completed
36 enrolled

Progesterone Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡